• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰高血糖素样肽-1 受体激动剂治疗患者的严重急性肾衰竭。

Severe acute renal failure in patients treated with glucagon-like peptide-1 receptor agonists.

机构信息

Department of Immunology and Diabetology, Hôpital Cochin, 27 rue du Faubourg Saint-Jacques, 75014 Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France.

Department of Immunology and Diabetology, Hôpital Cochin, 27 rue du Faubourg Saint-Jacques, 75014 Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France.

出版信息

Diabetes Res Clin Pract. 2014 Mar;103(3):e53-5. doi: 10.1016/j.diabres.2013.11.014. Epub 2013 Nov 20.

DOI:10.1016/j.diabres.2013.11.014
PMID:24447807
Abstract

We report two patients with diabetes in whom acute renal failure requiring hemodialysis occurred while on treatment with glucagon-like peptide-1 receptor agonists. We discuss the mechanisms of this complication and the potential for its prevention.

摘要

我们报告了两例糖尿病患者,他们在使用胰高血糖素样肽-1 受体激动剂治疗时发生了需要血液透析的急性肾衰竭。我们讨论了这种并发症的机制及其预防的可能性。

相似文献

1
Severe acute renal failure in patients treated with glucagon-like peptide-1 receptor agonists.胰高血糖素样肽-1 受体激动剂治疗患者的严重急性肾衰竭。
Diabetes Res Clin Pract. 2014 Mar;103(3):e53-5. doi: 10.1016/j.diabres.2013.11.014. Epub 2013 Nov 20.
2
Glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized clinical trials.2型糖尿病中胰高血糖素样肽-1受体激动剂:随机临床试验的荟萃分析。
Eur J Endocrinol. 2009 Jun;160(6):909-17. doi: 10.1530/EJE-09-0101. Epub 2009 Mar 24.
3
Glucagon-like peptide-1 receptor agonists and pancreatitis: a meta-analysis of randomized clinical trials.胰高血糖素样肽-1 受体激动剂与胰腺炎:随机临床试验的荟萃分析。
Diabetes Res Clin Pract. 2014 Feb;103(2):269-75. doi: 10.1016/j.diabres.2014.01.010. Epub 2014 Jan 14.
4
The extra-pancreatic effects of GLP-1 receptor agonists: a focus on the cardiovascular, gastrointestinal and central nervous systems.胰高血糖素样肽-1受体激动剂的胰腺外效应:聚焦于心血管系统、胃肠道和中枢神经系统
Diabetes Obes Metab. 2014 Aug;16(8):673-88. doi: 10.1111/dom.12251. Epub 2014 Jan 16.
5
The safety and tolerability of GLP-1 receptor agonists in the treatment of type-2 diabetes.GLP-1 受体激动剂在 2 型糖尿病治疗中的安全性和耐受性。
Int J Clin Pract. 2010 Sep;64(10):1402-14. doi: 10.1111/j.1742-1241.2010.02465.x.
6
Therapies for inter-relating diabetes and obesity - GLP-1 and obesity.治疗糖尿病和肥胖的相互关系的疗法——GLP-1 和肥胖。
Expert Opin Pharmacother. 2014 Dec;15(17):2487-500. doi: 10.1517/14656566.2014.965678. Epub 2014 Sep 26.
7
Glycaemic efficacy of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors as add-on therapy to metformin in subjects with type 2 diabetes-a review and meta analysis.GLP-1 受体激动剂和二肽基肽酶-4 抑制剂作为二甲双胍的附加疗法在 2 型糖尿病患者中的血糖疗效:综述和荟萃分析。
Diabetes Obes Metab. 2012 Aug;14(8):762-7. doi: 10.1111/j.1463-1326.2012.01603.x. Epub 2012 Apr 24.
8
Glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetes: differences and similarities.胰高血糖素样肽-1 受体激动剂治疗 2 型糖尿病:异同点。
Eur J Intern Med. 2014 Jun;25(5):407-14. doi: 10.1016/j.ejim.2014.03.005. Epub 2014 Mar 30.
9
GLP-1 provoked severe hypoglycemia in an individual with type 2 diabetes and a benign insulinoma.胰高血糖素样肽-1(GLP-1)在一名2型糖尿病合并良性胰岛素瘤患者中引发了严重低血糖。
Diabetes Care. 2014 Aug;37(8):e177-8. doi: 10.2337/dc14-0514.
10
Glucagon-like peptide receptor agonists and dipeptidyl peptidase-4 inhibitors in the treatment of diabetes: a review of clinical trials.胰高血糖素样肽受体激动剂和二肽基肽酶-4抑制剂治疗糖尿病:临床试验综述
Curr Opin Clin Nutr Metab Care. 2008 Jul;11(4):491-9. doi: 10.1097/MCO.0b013e328302f414.

引用本文的文献

1
Comparative efficacy and safety of GLP-1 receptor agonists for weight reduction: A model-based meta-analysis of placebo-controlled trials.胰高血糖素样肽-1受体激动剂用于减肥的疗效和安全性比较:基于模型的安慰剂对照试验荟萃分析
Obes Pillars. 2025 Jan 30;13:100162. doi: 10.1016/j.obpill.2025.100162. eCollection 2025 Mar.
2
The potential adverse effects of hypodermic glucagon-like peptide -1 receptor agonist on patients with type 2 diabetes: A population-based study.基于人群的研究:皮下注射胰高血糖素样肽-1 受体激动剂对 2 型糖尿病患者的潜在不良影响。
J Diabetes. 2024 Oct;16(10):e70013. doi: 10.1111/1753-0407.70013.
3
Semaglutide-associated kidney injury.
司美格鲁肽相关的肾损伤。
Clin Kidney J. 2024 Aug 13;17(9):sfae250. doi: 10.1093/ckj/sfae250. eCollection 2024 Sep.
4
Novel Insights into the Roles and Mechanisms of GLP-1 Receptor Agonists against Aging-Related Diseases.关于胰高血糖素样肽-1受体激动剂抗衰老相关疾病作用及机制的新见解
Aging Dis. 2022 Apr 1;13(2):468-490. doi: 10.14336/AD.2021.0928. eCollection 2022 Apr.
5
Polyethylene glycol loxenatide (PEX168) in subjects with renal impairment: A pharmacokinetic study.肾功能损害患者中聚乙二醇洛塞那肽(PEX168)的药代动力学研究。
Br J Clin Pharmacol. 2019 Dec;85(12):2714-2720. doi: 10.1111/bcp.14091. Epub 2019 Dec 8.
6
Exendin-4 Exacerbates Burn-Induced Morbidity in Mice by Activation of the Sympathetic Nervous System.Exendin-4 通过激活交感神经系统加剧小鼠烧伤引起的发病。
Mediators Inflamm. 2019 Jan 17;2019:2750528. doi: 10.1155/2019/2750528. eCollection 2019.
7
Post-transplant diabetes mellitus in patients with solid organ transplants.实体器官移植受者的移植后糖尿病。
Nat Rev Endocrinol. 2019 Mar;15(3):172-188. doi: 10.1038/s41574-018-0137-7.
8
Interactions between kidney disease and diabetes: dangerous liaisons.肾脏疾病与糖尿病之间的相互作用:危险关系。
Diabetol Metab Syndr. 2016 Jul 28;8:50. doi: 10.1186/s13098-016-0159-z. eCollection 2016.
9
Adverse Effects of GLP-1 Receptor Agonists.胰高血糖素样肽-1受体激动剂的不良反应
Rev Diabet Stud. 2014 Fall-Winter;11(3-4):202-30. doi: 10.1900/RDS.2014.11.202. Epub 2015 Feb 10.
10
Basal insulin combined incretin mimetic therapy with glucagon-like protein 1 receptor agonists as an upcoming option in the treatment of type 2 diabetes: a practical guide to decision making.基础胰岛素联合肠促胰岛素类似物疗法与胰高血糖素样肽-1受体激动剂作为2型糖尿病治疗的一种新兴选择:决策实用指南
Ther Adv Endocrinol Metab. 2014 Oct;5(5):95-123. doi: 10.1177/2042018814556099.